SUBSCRIBE
SUBSCRIBE
News   Drug Development

Study Backs Roche Holding AG’s (JOBS) New Use of Avastin Cancer Drug

August 18, 2009 | 
1 min read
Bookmark and Share

Reuters -- Swiss-based Roche Holding AG said on Tuesday a study had showed its drug Avastin increased life expectancy for women with breast cancer without the disease getting worse, when used alongside common chemotherapies.
Clinical research Phase 3 Europe
MORE ON THIS TOPIC
Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.
Insights
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
July 27, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
Chess made from China and EU, USA flags. Europe Union, USA and China relations
China
Summit, Merck must navigate new regulatory terrain in China-first cancer landscape
July 27, 2026
 · 
10 min read
 · 
Heather McKenzie
Close-up view of a vivid blue railway signal light illuminating a track at golden hour sunset, providing crucial safety guidance for efficient train operations and future transportation
CAR-T
Lilly, AbbVie climb aboard in vivo CAR T train—but safety remains a hurdle
July 27, 2026
 · 
8 min read
 · 
Tristan Manalac
pipeline infographic, industrial background, oil water gas transportation yellow pipes, plumbing system vector illustration
Drug Development
Sanofi’s $1.4B Kymab bet falters again as atopic dermatitis trials scrapped
July 24, 2026
 · 
3 min read
 · 
Gabrielle Masson